| Issue |
Title |
File |
| Vol 4, No 3 (2017) |
Академику Михаилу Ивановичу Давыдову – 70 лет |
(Rus)
|
|
.
|
| Vol 8, No 3 (2021) |
Сравнительное исследование хромогранина А и хромогранина В у больных с нейроэндокринными опухолями желудка и поджелудочной железы |
(Rus)
|
|
Lyubimova N.V., Timofeev Y.S., Lebedeva A.V., Kushlinskii N.E.
|
| Vol 12, No 3 (2025) |
In vitro models of soft tissue sarcomas: basic and clinical aspects |
(Rus)
|
|
Bokova U.A., Tretyakova M.S., Kozlova P.K., Korobeynikova A.A., Menyailo M.E., Gerashchenko T.S., Denisov E.V.
|
| Vol 10, No 2 (2023) |
In vivo models in cancer research |
(Rus)
|
|
Bokova U.A., Tretyakova M.S., Schegoleva A.A., Denisov E.V.
|
| Vol 11, No 2 (2024) |
LINE-1 hypomethylation and HIST1H4F hypermethylation as oncomarkers in liquid biopsy of colorectal cancer |
(Rus)
|
|
Kondratova V.N., Botezatu I.V., Stroganova A.M., Dranko S.L., Lichtenstein A.V.
|
| Vol 9, No 1 (2022): Приложение |
3‑Hydroxyquinazoline derivatives, analogues of erastin, induced ferroptosis in breast cancer cells Additional material |
(Rus)
|
|
Borisova L.M., Osipov V.N., Golubeva I.S., Kiseleva M.P., Khochenkov D.A., Vartanian A.A.
|
| Vol 9, No 1 (2022) |
3-Hydroxyquinazoline derivatives, analogues of erastin, induced ferroptosis in breast cancer cells |
(Rus)
|
|
Borisova L.M., Osipov V.N., Golubeva I.S., Kiseleva M.P., Hochenkov D.A., Vartanyan A.A.
|
| Vol 11, No 2 (2024) |
A modern view of the role of genetic factors in the etiopathogenesis of breast cancer |
(Rus)
|
|
Pavlova N.V., Dyomin S.S., Churnosov M.I., Ponomarenko I.V.
|
| Vol 5, No 2 (2018) |
A STUDY OF THE ROLE OF MICRORNA IN PITUITARY ADENOMA |
(Rus)
|
|
Gareev I.F., Beylerli O.A.
|
| Vol 9, No 4 (2022) |
Aberrations of DNA methylation in cancer |
(Rus)
|
|
Maksimova V.P., Usalka O.G., Makus Y.V., Popova V.G., Trapeznikova E.S., Khayrieva G.I., Sagitova G.R., Zhidkova E.M., Prus A.Y., Yakubovskaya M.G., Kirsanov K.I.
|
| Vol 5, No 3 (2018) |
Ability to form duplexes as a factor of intracellular microRNA distribution |
(Rus)
|
|
Kuzmichev S.A., Komelkov A.V., Tchevkina E.M.
|
| Vol 4, No 4 (2017) |
ABOUT RENAL CAPSULE TUMOUR HISTOGENESIS, INDUCED BY 1,2-DIMETHYLHYDRAZINE IN CBA MICE |
(Rus)
|
|
Morozova O.V., Antoshina Е.Е., Manskikh V.N.
|
| Vol 4, No 1 (2017) |
Actin isoforms and neoplastic transformation |
(Rus)
|
|
Dugina V.B., Shagieva G.S., Khromova N.V., Kopnin P.B.
|
| Vol 3, No 1 (2016) |
Allele-specific gene expression in carcinogenesis |
(Rus)
|
|
Krivtsova O.M., Lazarevich N.L.
|
| Vol 1, No 2 (2014) |
Amniocar as a proliferative medium for mesenchymal cells |
(Rus)
|
|
Chestkov V.V., Tabakov V.Y., Shchepkina Y.V.
|
| Vol 7, No 3 (2020) |
Analysis of genetic aberrations in pediatric high-grade gliomas |
(Rus)
|
|
Zaytseva M.A., Shekhtman A.P., Papusha L.I., Valiakhmetova E.F., Yasko L.A., Druy A.E.
|
| Vol 11, No 1 (2024) |
Analysis of miRNAs miR-125a-5p, -27a-5p, -193a-5p, -135b-5p, -451a, -495-3p and -136-5p in parental ovarian cancer cells and secreted extracellular vesicles |
(Eng)
|
|
Skryabin G.O., Beliaeva A.A., Enikeev A.D., Bagrov D.V., Keremet A.M., Komelkov А.V., Elkin D.S., Sylantieva D.M., Tchevkina E.M.
|
| Vol 4, No 4 (2017) |
ANALYSIS OF RELATIVE EXPRESSION OF THE HMGA2 GENE AND ONCOGENIC MICRORNA-221 IN CYTOLOGICAL SLIDES OBTAINED BY A FINE-NEEDLE ASPIRATION BIOPSY OF THE THYROID NODULES |
(Rus)
|
|
Titov S.E., Ivanov M.K., Tsivlikova E.V., Ganzha M.S., Malakhina E.S., Malek A.V., Poloz T.L., Shevchenko S.P., Kolesnikov N.N.
|
| Vol 7, No 1 (2020) |
Analysis of systemic immunity and inflammation in the prognosis of gastric adenocarcinoma |
(Rus)
|
|
Khakimova G.G., Zabotina T.N., Tryakin A.A., Borunova A.A., Davidova T.V., Kalinin A.E., Vakhabova Y.V., Zakharova E.N., Tabakov D.V.
|
| Vol 10, No 4 (2023) |
Analysis of the expression of matrix RNA of a panel of genes of morphologically unchanged rectal epithelium as a method of early diagnosis of colon pathology |
(Rus)
|
|
Bozhenko V. ., Goncharov S.V., Zakharenko M.V., Kiseleva Y.Y., Karmakova T.A., Kulinich T.M., Stanoevich U.S., Melnikova N.V., Senchukova A.L., Grunin .B., Bliznyukov O. ., Solodky V.A.
|
| Vol 6, No 4 (2019) |
Anti-cancer activity of сuraxin CBL0137 on the models of acute leukemia in vitro |
(Rus)
|
|
Fetisov T.I., Kirsanov K.I., Borunova A.A., Zatsepina M.N., Lesovaya E.A., Zabotina T.N., Belitsky G.A., Yakubovskaya M.G.
|
| Vol 11, No 3 (2024) |
Antiproliferative effect of wild berries and North-Eastern Siberian bulbous spleen carp on breast cancer cells MCF-7 |
(Rus)
|
|
Egorov A.N., Tikhonov D.G., Golderova A.S.
|
| Vol 9, No 2 (2022) |
Antitumor effect of recombinant interferon-gamma in an experimental model of Ehrlich’s bilateral solid carcinoma |
(Rus)
|
|
Isaeva V.G., Grivtsova L.Y., Zhovtun L.P., Samborsky S.M., Falaleeva N.A.
|
| Vol 3, No 3 (2016) |
Antitumor effect of the curaxin CBL0137 on the models of colon cancer |
(Rus)
|
|
Fetisov T.I., Tilova L.R., Lesovaya E.A., Antoshina E.E., Gor’kova T.G., Trukhanova L.S., Morozova O.V., Shipaeva E.V., Ivanov R.V., Purmal A.A., Belitskiy G.A., Yakubovskaya M.G., Gudkov A.V., Gurova K.V., Kirsanov K.I.
|
| Vol 11, No 3 (2024) |
Anti-tumor effects of recombinant human cyclophilin A combined with immune checkpoint inhibitors in the experimental model of melanoma B16 in vivo |
(Rus)
|
|
Kalinina A.A., Kazansky D.B., Khromykh L.M.
|
| Vol 7, No 4 (2020) |
Antitumor proteinkinase inhibitor imatinib may be regarded as a potential correcting agent for COVID-19 associated pulmonary fibrosis |
(Rus)
|
|
Mikhaylova I.N., Treshalina N.M., Shubina I.Z., Manina I.V., Kiselevsky M.V., Lukashev A.N.
|
| Vol 6, No 2 (2019) |
Ascitis as a unique microenvironment of tumors in ovarian cancer: interaction with prognosis and chemoresistance |
(Rus)
|
|
Villert A.B., Kolomiets L.A., Yunusova N.V.
|
| Vol 6, No 1 (2019) |
Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer |
(Rus)
|
|
Spirina L.V., Gorbunov A.K., Kondakova I.V., Usynin E.A., Slonimskaya E.M.
|
| Vol 5, No 1 (2018) |
Asynchronous replication in oncological patients |
(Rus)
|
|
Mikhailova G.F., Tsepenko V.V., Shkavrova T.G., Goloub E.V.
|
| Vol 6, No 2 (2019) |
Asynchronous replication of AURKA and TP53 genes in gastric cancer patients and patients with multiple tumors |
(Rus)
|
|
Tsepenko V.V., Mikhailova G.F., Shkavrova T.G., Goloub E.V., Rukhadze G.O., Skoropad V.Y.
|
| Vol 6, No 1 (2019) |
Autoantibodies against tumor-associated antigens as one class of serological markers |
(Rus)
|
|
Marshutina N.V., Sergeeva N.S., Alentov I.I., Kaprin A.D.
|
| Vol 9, No 4 (2022) |
Autophagy activation in breast cancer cells in vitro after the treatment with PI3K/AKT/mTOR inhibitors |
(Eng)
|
|
Grigoreva D.D., Zhidkova E.M., Lylova E.S., Enikeev A.D., Kirsanov K.I., Belitsky G.A., Yakubovskaya M.G., Lesovaya E.A.
|
| Vol 2, No 1 (2015) |
Biochemical criteria of toxicity of therapy with high doses of methotrexate in children with osteosarcoma |
(Rus)
|
|
Strizhevskaya A.M., Golovnya E.G., Dzampaev A.Z., Baykova V.N.
|
| Vol 9, No 4 (2022) |
Biochemical factors in the blood serum of neuroendocrine tumor patients with carcinoid syndrome |
(Rus)
|
|
Lyubimova N.V., Timofeev Y.S., Lebedeva A.V., Artamonova A.V., Stilidi I.S., Kushlinskii N.E.
|
| Vol 2, No 1 (2015) |
Biochemical markers of bone metastasis |
(Rus)
|
|
Lyubimova N.V., Kushlinskiy N.E.
|
| Vol 11, No 3 (2024) |
Blood plasma lipid profile in glial tumors |
(Rus)
|
|
Obukhova L.M., Balavina E.V., Veselova T.A., Medyanik I.A., Grishin A.S., Lazukin V.F., Kontorshchikov M.M.
|
| Vol 5, No 1 (2018) |
BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer |
(Rus)
|
|
Tsyganov M.M., Ibragimova M.K., Deryusheva I.V., Kazantseva P.V., Garbukov E.Y., Slonimskaya E.M., Litviakov N.V.
|
| Vol 10, No 1 (2023) |
Breast cancer association with oncogenic papillomaviruses: arguments pro and con |
(Rus)
|
|
Volgareva G.M.
|
| Vol 9, No 2 (2022) |
Breast cancer association with oncogenic papillomaviruses: papillomaviral DNA detection in breast cancer cells |
(Rus)
|
|
Volgareva G.M.
|
| Vol 4, No 2 (2017) |
Cancer as a result of genetic mosaicism |
(Rus)
|
|
Likhtensteyn A.V.
|
| Vol 6, No 1 (2019) |
Celebrating the centenary of Professor Nikolay Petrovich Mazurenko's birth |
(Rus)
|
|
Gurtsevich V.E., Mazurenko N.N.
|
| Vol 10, No 2 (2023) |
Cell-free plasma miRNAs analysis for low invasive lung cancer diagnostics |
(Rus)
|
|
Konoshenko M.Y., Laktionov P.P., Lancuhaj Y.A., Pak S.V., Krasilnikov S.E., Bryzgunova O.E.
|
| Vol 10, No 4 (2023) |
Cellular microenvironment as an object of targeted therapy for malignant neoplasms |
(Rus)
|
|
Zyablitskaya E.Y., Kubyshkin A.V., Sorokina L.E., Serebryakova A.V., Aliev K.A., Maksimova P.E., Lazarev A.E., Balakchina A.I., Golovkin I.O.
|
| Vol 11, No 4 (2024) |
Changes in the expression of genes that regulate apoptosis as a factor in the development of chemoresistance in soft tissue sarcoma |
(Rus)
|
|
Fetisov T.I., Khazanova S.A., Shtompel P.A., Trapeznikova E.S., Tararykova A.A., Zinovyeva V.Y., Marshall V.I., Lowenger A.A., Kupaeva I.S., Rogozhin D.V., Bokhyan A.Y., Belitsky G.A., Yakubovskaya M.G., Kirsanov K.I.
|
| Vol 6, No 3 (2019) |
Changes of exosomal matrix metalloproteinases level in colorectal cancer associated with sex and metabolic disturbance |
(Rus)
|
|
Yunusova N.V., Zambalova E.A., Patysheva M.R., Dimcha A.A., Cheremisina O.V., Afanas’ev S.G., Kondakova I.V.
|
| Vol 10, No 4 (2023) |
Characteristics of adaptive immune effectors involved in the secondary xenogeneic immune response to human melanoma cells |
(Rus)
|
|
Persiyantseva N.A., Kalinina A.A., Zamkova M.A., Khromykh L.M., Kazansky D.B.
|
| Vol 5, No 4 (2018) |
Chemoresistance of PRAME-expressing melanoma cell can be resolved with help of bortezomib |
(Rus)
|
|
Misyurin V.A., Kalenichenko D.V., Rudakova A.A., Finashutina Y.P., Lyzhko N.A., Tikhonova V.V., Kesaeva L.A., Solopova O.N., Misyurina A.Е., Velikanov A.N., Baryshnikovа M.А., Misyurin A.V.
|
| Vol 4, No 3 (2017) |
Chemotherapy: some potential risks under antineoplastic drugs handling |
(Rus)
|
|
Solenova L.G., Yakubovskaya M.G.
|
| Vol 8, No 3 (2021) |
Circulating predictive markers of immune checkpoint inhibitors in non-small cell lung cancer |
(Rus)
|
|
Musaelyan A.A., Akopov A.L., Lapin S.V., Nazarov V.D., Fillipov D.I., Emanuel V.L., Orlov S.V.
|
| Vol 6, No 4 (2019) |
Clinical, anamnestic, molecular and genetic criteria for Lynch syndrome |
(Rus)
|
|
Semyanikhina A.V., Pospekhova N.I., Filippova M.G., Golovina D.A., Rasulov A.O., Lyubchenko L.N.
|
| Vol 6, No 2 (2019) |
Clinical and genetic aspects of differential diagnostics of hereditary non-polyposis colorectal cancer |
(Rus)
|
|
Semyanikhina A.V., Rasulov A.O., Lyubchenko L.N.
|
| Vol 12, No 1 (2025) |
Clinical and laboratory significance of soluble claudin-5 and VEGF in ovarian cancer |
(Rus)
|
|
Kushlinskii N.E., Kulikova S.E., Gugnin F.A., Nezhdanova S.Y., Gratchev A.N., Utkin D.O., Tsekatunov D.A., Ryzhavskaya I.B., Kushlinskiy D.N., Gershtein E.S., Stilidi I.S.
|
| Vol 4, No 1 (2017) |
Clinical and morphological characteristics of neuroendocrine tumors: clinical experience |
(Rus)
|
|
Raskin G.A., Ivanova A.K., Orlova R.V.
|
| Vol 8, No 2 (2021) |
Clinical and morphological portrait of tumors with microsatellite instability |
(Rus)
|
|
Musaelyan A.A., Nazarov V.D., Budnikova A.S., Lapin S.V., Vorobyev S.L., Emanuel V.L., Zakharenko A.A., Orlov S.V.
|
| Vol 5, No 3 (2018) |
Clinical, morphological, and molecular genetic predictors of metastatic lesions in the regional lymph nodes in breast cancer |
(Rus)
|
|
Dergunova Y.A., Podionov V.V., Bozhenko V.K., Kometova V.V., Dardyk M.V.
|
| Vol 11, No 4 (2024) |
Clinical significance of long non-coding RNA expression in esophageal cancer depending on the phenotype of the tumor stroma |
(Eng)
|
|
Kovaleva O.V., Podlesnaya P.A., Kudinova E.S., Rashidova M.A., Mochalnikova V.V., Gratchev A.N.
|
| Vol 9, No 1 (2022) |
Clinical significance of the phenotype of immune cells of the tumor stroma of prostate cancer |
(Rus)
|
|
Podlesnaya P.A., Kovaleva O.V., Rashidova M.A., Samoilova D.V., Petrenko A.A., Mochalnikova V.V., Gratchev A.N.
|
| Vol 12, No 3 (2025) |
Clonal hematopoiesis of indeterminate potential and malignant neoplasms |
(Rus)
|
|
Shevchenko V.E., Kushnir T.I., Gudkova M.V., Arnotskaya N.E.
|
| Vol 12, No 1 (2025) |
CNA landscape of HER2-negative breast cancer during administration of taxane-containing schemes of neoadjuvant chemotherapy |
(Rus)
|
|
Ibragimova M.K., Kravtsova E.A., Tsyganov M.M., Litviakov N.V.
|
| Vol 10, No 2 (2023) |
Comparative assessment of the exosomal tumor-associated microRNA levels in blood plasma and ascitic fluid in ovarian cancer patients |
(Rus)
|
|
Dzhugashvili E.I., Yunusova N.V., Yalovaya A.I., Grigorieva A.E., Sereda E.E., Kolomiets L.A., Tamkovich S.N.
|
| Vol 6, No 2 (2019) |
Comparison of molecular genetic methods of detection of mutations in the CALR gene in myeloproliferative disorders |
(Rus)
|
|
Kesaeva L.A., Bulanov A.Y., Finashutina Y.P., Tikhonova V.V., Solopova O.N., Misyurina E.N., Kasatkina N.N., Lyzhko N.A., Misyurin V.A., Turba A.A., Solodovnik A.A., Soldatova I.N., Misyurin A.V.
|
| Vol 9, No 1 (2022) |
Comprehensive analysis of chromosome 8 abnormalities and its prognostic value in patients with uveal melanoma |
(Rus)
|
|
Yarovaya V.A., Yarovoy A.A., Chudakova L.V., Levashov I.A., Zaretskiy A.R.
|
| Vol 11, No 1 (2024) |
Contemporary views on the clinical, epidemiological and molecular genetic characteristics of melanoma of the skin and mucous membranes |
(Rus)
|
|
Bogdanova V.A., Spirina L.V., Chizhevskaya S.Y., Kovaleva I.V., Nikulnikov K.V.
|
| Vol 10, No 3 (2023) |
Continuous ultraviolet irradiation induces the development of irreversible resistance of melanoma cells to anticancer drugs |
(Rus)
|
|
Shchegolev Y.Y., Karpukhina M.A., Sorokin D.V., Scherbakov A.M., Andreeva O.E., Razuvaeva V.E., Bogush T.A., Mikhaylova I.N., Demidov L.V., Gudkova M.V., Krasil’nikov M.A.
|
| Vol 2, No 2 (2015) |
CRABP proteins – relatives or homonyms? |
(Rus)
|
|
Tchevkina E.M., Favorskaya I.A.
|
| Vol 7, No 1 (2020) |
Current approaches to assessment of the impact of the environmental contamination on cancer risk |
(Rus)
|
|
Solenova L.G.
|
| Vol 10, No 3 (2023) |
Current approaches to systemic treatment of BRCA-associated triple-negative breast cancer |
(Rus)
|
|
Enaldieva D.A., Krivorotko P.V., Imyanitov E.N., Zhiltsova E.K., Donskikh R.V., Shaikhelislamova L.F., Gigolaeva L.P., Semiglazov V.F.
|
| Vol 4, No 4 (2017) |
CYCLOPHILIN A: STRUCTURE AND FUNCTIONS |
(Rus)
|
|
Kalinina A.A., Khromykh L.M., Kazansky D.B.
|
| Vol 5, No 3 (2018) |
Cytotoxic cationic peptides as а ligands for receptor nucleolin |
(Rus)
|
|
Lushnikova A.A., Kostarev A.V., Ponkratova D.A., Onyan A.V., Glubokova E.G., Andreev S.M.
|
| Vol 12, No 2 (2025) |
Cytotoxicity mechanisms of passive anti-GD2 immunotherapy in pediatric tumors |
(Rus)
|
|
Melnikov M.E., Kulyova S.A., Kondratiev G.V., Vasilyeva M.M., Savelieva O.E.
|
| Vol 11, No 1 (2024) |
Decreasing the ability of HCT116 cells to escape from therapy induced senescence by increasing the duration of doxorubicin treatment |
(Rus)
|
|
Persiyantseva N.A., Vikhrova S.Y., Korotkova M.S., Kazansky D.B., Tatarsky V.V., Zamkova M.A.
|
| Vol 11, No 2 (2024) |
Depolymerization of tubulin as the main molecular mechanism of the cytotoxic and antitumor activity of pyrrole-containing heterocyclic compounds |
(Rus)
|
|
Galembikova A.R., Dunaev P.D., Ivoilova T.V., Gilyazova A.I., Galyautdinova A.E., Mikheeva E.G., Zykova S.S., Igidov N.M., Kopnin P.B., Boichuk S.V.
|
| Vol 4, No 1 (2017) |
Detection of gene mutations in genome “hot” spots: “hairpin” amplicons in DNA melting analysis |
(Rus)
|
|
Kondratova V.N., Botezatu I.V., Shelepov V.P., Lichtenstein A.V.
|
| Vol 6, No 4 (2019) |
Determination of chemoresistance of ovarian cancer cells in vitro |
(Rus)
|
|
Kuzin K.A., Fetisov T.I., Knyazev R.I., Fomina L.Y., Meheda L.V., Lesovaya E.A., Belitsky G.A., Yakubovskaya M.G., Kirsanov K.I.
|
| Vol 11, No 4 (2024) |
Development of an in vitro model to study the role of disulfide bonds in the largest extracellular domain of the sodium-dependent phosphate transporter NaPi2b in OVCAR-8 ovarian carcinoma cells |
(Rus)
|
|
Skripova V.S., Firsova D.A., Kilunov A.V., Bulatova L.F., Poputsky M.A., Kiyamova R.G.
|
| Vol 10, No 1 (2023) |
Dexamethasone effects on the expression and content of glycosylated components of mouse brain tissue |
(Rus)
|
|
Aladev S.D., Sokolov D.K., Strokotova A.V., Kazanskaya G.M., Volkov A.M., Politko M.O., Shahmuradova A.I., Kliver E.E., Tsidulko A.Y., Aidagulova S.V., Grigorieva E.V.
|
| Vol 9, No 4 (2022) |
Diagnostic and prognostic value of long non-coding RNA PROX1‑AS1 and miR-647 expression in gastric cancer |
(Rus)
|
|
Vetchinkina E.A., Kalinkin A.I., Kuznetsova E.B., Kiseleva A.E., Alekseeva E.A., Nemtsova M.V., Bure I.V.
|
| Vol 11, No 3 (2024) |
Diagnostic potential of miRNA-135A1 in human papillomavirus associated cervical lesions |
(Rus)
|
|
Elkin D.S., Taubinskaya M.I., Elkina N.V., Faskhutdinov R.S., Fedorova M.D., Katargin A.N., Zhordania K.I., Mustafina E.A., Grivachev E.A., Pavlova L.S., Vinokurova S.V.
|
| Vol 2, No 2 (2015) |
Diagnostic significance of DNA and antibodies against capsid antigens of anti-Epstein–Barr virus antibodies levels in blood plasma of nasopharyngeal carcinoma patients from non-endemic region |
(Rus)
|
|
Gurtsevich V.E., Senyuta N.B., Kondratova V.N., Goncharova E.V., Ignatova A.V., Lomaya M.V., Kropotov M.A., Mudunov A.M., Lichtenstein A.V.
|
| Vol 6, No 3 (2019) |
Differences in the profile of cytokine expression induced by implantation of oncogenic and non-oncogenic millipore filters |
(Rus)
|
|
Rybalkina E.Y., Susova O.Y., Moizhess T.G.
|
| Vol 7, No 2 (2020) |
Differential expression of microRNAs and their target genes in cervical intraepithelial neoplasias of varying severity |
(Rus)
|
|
Dimitriadi T.A., Burtsev D.V., Dzhenkova E.A., Kutilin D.S.
|
| Vol 11, No 1 (2024) |
Dynamics of miRNA expression in urine extracellular vesicles of prostate cancer patients after radical prostatectomy |
(Rus)
|
|
Shutko E.V., Bryzgunova O.E., Ostal’cev I.A., Pak S.V., Krasi’nikov S.E., Laktionov P.P., Konoshenko M.Y.
|
| Vol 12, No 2 (2025) |
Dynamics of subpopulations of CD15+CD66b+ and CD62L+CD63+ circulating neutrophils in patients with benign neoplasms and progression of kidney cancer |
(Rus)
|
|
Myagdieva I.R., Abakumova T.V., Dolgova D.R., Gorshkov O.Y., Gening T.P., Zaineeva R.S., Timofeeva S.A.
|
| Vol 4, No 4 (2017) |
EARLY DIAGNOSTICS AND TOTAL GASTRECTOMY OF HEREDITARY DIFFUSE GASTRIC CANCER |
(Rus)
|
|
Lyubchenko L.N., Filippova M.G., Anurova O.A., Nazliev P.B., Stilidi I.S., Davydov M.M.
|
| Vol 4, No 1 (2017) |
Effect of acadesine on breast cancer cells under hypoxia |
(Rus)
|
|
Shcherbakov A.M., Vavilov N.E., Andreeva O.E., Tyaglov B.V., Mironov A.S., Shakulov R.S., Lobanov K.V., Yarotskiy S.V., Shtil’ A.A.
|
| Vol 8, No 1 (2021) |
Effect of caveolin-1 knockdown on the protein composition of extracellular vesicles secreted by non-small cell lung cancer cells |
(Rus)
|
|
Skryabin G.O., Komelkov A.V., Kopnin P.B., Nikishin I.I., Kuzmichev S.A., Tchevkina E.M.
|
| Vol 7, No 4 (2020) |
Effect of CRABP1 expression on the proliferation and the sensitivity to retionoic acid of breast cancer cells of different origin |
(Rus)
|
|
Enikeev A.D., Komelkov A.V., Axelrod M.E., Galetsky S.A., Tchevkina E.M.
|
| Vol 7, No 3 (2020) |
Effect of the exosome-mediated suppression of the estrogen signaling: the role in the progression of the hormonal resistance of breast cancer cells |
(Rus)
|
|
Sorokin D.V., Andreeva O.E., Mikhaevich E.I., Shchegolev Y.Y., Scherbakov A.M., Gudkova M.V., Krasil’nikov M.A.
|
| Vol 12, No 2 (2025) |
Effect of the reverse transcriptase inhibitor efavirenz on 5-azacytidine-induced LINE1 long interspersed repeat expression and genetic instability in acute myeloid leukemia cells |
(Rus)
|
|
Magomedova K.M., Antonova I.A., Strelkov M.S., Nurtdinova V.A., Cheshchevik V.T., Kirsanov K.I., Belitsky G.A., Yakubovskaya M.G., Vlasova O.A.
|
| Vol 11, No 4 (2024) |
Effects of a novel HSP90 inhibitor on estrogen receptor α signaling pathways in breast cancer cells |
(Rus)
|
|
Scherbakov A.M., Sorokin D.V., Salnikova D.I., Gudkova M.V., Andreeva O.E., Mikhaylova A.L., Varabyeva N.A., Piven Y.A.
|
| Vol 8, No 4 (2021) |
Efficiency in different immunotherapy of cancer: literature review |
(Rus)
|
|
Gaptulbarova K.A., Tsyganov M.M., Ibragimova M.K., Pevzner A.M., Spirina L.V., Litviakov N.V.
|
| Vol 1, No 2 (2014) |
Endocytosis of the IFNAR1 chain of Type 1 interferon receptor is regulated by diverse E2 ubiquitin conjugation enzymes |
(Rus)
|
|
., ., .
|
| Vol 1, No 2 (2014) |
Endocytosis of the IFNAR1 chain of Type 1 interferon receptor is regulated by diverse E2 ubiquitin conjugation enzymes |
(Rus)
|
|
J. Carbone C., Zheng H., Y. Fuchs S.
|
| Vol 6, No 3 (2019) |
Epidemiological monitoring of cancer risk in cancer center workers |
(Rus)
|
|
Solenova L.G.
|
| Vol 12, No 2 (2025) |
Epstein–Barr virus and mechanisms of molecular carcinogenesis |
(Rus)
|
|
Molchanov A.D., Vasilyeva A.S., Smirnova K.V., Nemtsova M.V.
|
| Vol 5, No 3 (2018) |
Epstein–Barr virus in the ethnic Tatars population: the infection and sequence variants of LMP1 oncogene |
(Rus)
|
|
Smirnova K.V., Senyuta N.B., Botezatu I.V., Dushenkina T.E., Lubenskaya A.K., Frolovskaya A.A., Petrov S.V., Lichtenstein A.V., Gurtsevitch V.E.
|
| Vol 9, No 3 (2022) |
Epstein-Barr virus in Adygeans and Slavs in Russia: virus types, LMP1 variants, and malignant tumors |
(Rus)
|
|
Smirnova K.V., Senyuta N.B., Lubenskaya A.K., Botezatu I.V., Dushenkina T.E., Lichtenstein A.V., Gurtsevich V.E.
|
| Vol 1, No 1 (2014) |
Epygenetic regulation of gene expression in virus-associated human tumors |
(Rus)
|
|
Kisseljova N.P., Kisseljov F.L.
|
| Vol 4, No 3 (2017) |
Erythrocyte diagnosticum as used in revealingmalignant process |
(Rus)
|
|
Savluchinskayа L.A., Bakulin I.A., Molodyk A.A.
|
| Vol 1, No 1 (2014) |
Estrogen-dependent signaling pathways and their role in the tumor progression: progress and perspectives |
(Rus)
|
|
Krasil’nikov M.A., Shcherbakov A.M.
|
| 1 - 100 of 380 Items |
1 2 3 4 > >> |
